Racial and Sex Differences in the Response to First-Line Antihypertensive Therapy
- 1Department of Physiology and Biophysics, Center for Computational Medicine, University of Mississippi Medical Center, Jackson, MS, United States
- 2Department of Data Science, John D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS, United States
A Corrigendum on
Racial and Sex Differences in the Response to First-Line Antihypertensive Therapy
by Clemmer, J. S., Pruett, W. A., and Lirette, S. T. (2020). Front. Cardiovasc. Med. 7:608037. doi: 10.3389/fcvm.2020.608037
In the original article, there was a mistake in Figures 1, 2 and 3 as published. These figures did not have any statistical markers or correct headings. The corrected Figures 1, 2 and 3 appear below.
Figure 1. Adjusted overall responses in treated hypertensives in terms of change in mean blood pressure (A) and proportion of blood pressure control (B) with means and 95% CI shown adjusted for age, BMI, drug dose, and baseline blood pressure. *p < 0.05 vs. all.
Figure 2. Adjusted proportion of blood pressure control after treatment with each drug class in white and black males and females adjusted for age, BMI, dosage, and baseline blood pressure (means and 95% CI shown). *p < 0.05 vs. Untreated, +p < 0.05 vs. THZ, #p < 0.05 vs. White, %p < 0.05 vs. Male.
Figure 3. Estimated change in systolic (A) and diastolic (B) blood pressure at 6 months after each drug in white and black males and females with means and 95% CI shown adjusted for age, BMI, dosage, and baseline blood pressure. *p < 0.05 vs. Untreated, +p < 0.05 vs. THZ, #p < 0.05 vs. White, %p < 0.05 vs. Male.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: hypertension, black, race, antihypertensive therapy, first line treatment
Citation: Clemmer JS, Pruett WA and Lirette ST (2021) Corrigendum: Racial and Sex Differences in the Response to First-Line Antihypertensive Therapy. Front. Cardiovasc. Med. 7:643289. doi: 10.3389/fcvm.2020.643289
Received: 17 December 2020; Accepted: 22 December 2020;
Published: 21 January 2021.
Edited and reviewed by: Michel Burnier, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland
Copyright © 2021 Clemmer, Pruett and Lirette. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: John S. Clemmer, amNsZW1tZXJAdW1jLmVkdQ==